Advertisement

Picture BIO Deutschland German Corona Special 2021 Digital 650x80px

Persons > All

Find below all kinds of persons.

Total search results: 7469 | Ordered by Person (ascending)
next pagenext page 1 2 3 ... 67 68 69 ... 73 74 75  next pagenext page

order ascendingorder descendingPerson order ascendingorder descendingPosition order ascendingorder descendingOrganisation (Group) order ascendingorder descendingCountry
Van den Berghe, Jan (Genohm 201503 Financial Director) Chief Financial Officer (CFO) Agilent (Group) Switzerland
Van den Brulle, Jan (Sloning BioTechnology 201004 Scientific Director R&D) Research & Development Manager MorphoSys (Group) Germany
van den Dool, Gerrit (SigmaAlrich 199901– Head European Sales) Sales Manager / Marketing Manager Merck (DE) (Group) United States (USA)
van den Hoven, Ton (SurgVision 201710 CEO) Chief Executive Officer (CEO) Bracco (Group) Netherlands
van der Broek, Lykele (Bayer 201012 COO Bayer CropScience before Bayer Animal Health 200610– division head) Chief Operating Officer (COO) Bayer (Group) Germany
Van der Geyten, Serge (JnJ 201501 Director for Neuroscience External Affairs at Janssen Pharmaceutica NV) Business Development Manager / Strategy Manager Johnson & Johnson (JnJ) (Group) Belgium
Van der Heide, Teun (Lonza 201303 Head Lonza Bioscience) President/Director/Head Business Group/Unit/Division Lonza (Group) Switzerland
van der Horst, Robert-Jan (Equinet Bank 201410 Research Analyst) Analyst (Financial / Industry) Equinet (Group) Germany
van der Knaap, Rob (Spark Holland 200804– President ) President/Director/Head Business Group/Unit/Division Spark Holland (Group) Netherlands
van der Meer, Edward (Healthy Aging Campus Netherlands 201410 Managing Director) Cluster Manager Healthy Ageing Campus Netherlands Netherlands
van der Veen, Lars (iOnctura 201706– COO before Solvay Pharma + Organon + Boehringer Ingelheim) Chief Operating Officer (COO) iOnctura (Group) Switzerland
van der Velden, Frank-Jan (Xpand Biotechnology 201612 Head Business Affairs + Finance) Chief Business Officer (CBO) Kuros (Group) Netherlands
van der Zande, Piet (Thermo Fisher 201006 Managing Director Thermo Fisher Scientific GmbH) Managing Director Thermo Fisher (Group) Germany
van Dessel, Vincent (Euronext 201511 CEO of Euronext Brussels) Chief Executive Officer (CEO) Euronext (Group) Belgium
van Deventer, Sander (Forbion 201204 General Partner) General Partner (venture partner) Forbion Capital Partners (NL) Netherlands
van Duijnhoven, Henk (Danaher 201409 SVP Dental Segment) President/Director/Head Business Group/Unit/Division Danaher (Group) United States (USA)
van Gool, Alain (Univ Nijmegen 201904 Prof + Head of CoE for Translational Omics) Professor University of Nijmegen (Radboud University) Netherlands
van Gorp, Jasper (Gilde Investment 201708 Managing Partner at Gilde Healthcare) Managing Partner Gilde Investment (Group) Netherlands
van Hagen, Paul (Xeltis 201602– CFO before Prosensa + Crucell + Ernst & Young) Chief Financial Officer (CFO) Xeltis (Group) Switzerland
van Hall, Andre (BioCampus Cologne 201307– Prokurist before BioMedizinZentrum Dortmund) n. a. BioCampus Cologne Management GmbH Germany
Van Hauwermeiren, Tim (Argen-X 201101 CEO before Ablynx BusDev Manager before P&G) Chief Executive Officer (CEO) Argenx (Argen-X) (Group) Netherlands
Van Heekeren, Robbert (Byondis 202009– CFO before Odyssee Mobile + Kiadis Pharma + Proxy Laboratories + Organon) Chief Financial Officer (CFO) Byondis (Group) Netherlands
van Hoeven, Kees (Netherlands (govt) 201405 RVO) Administrative Officer (personnel) Netherlands (govt) Netherlands
van Houten, François Adrianus (Frans) (Philips 201104– designated CEO before since 1986 at Philips) Chief Executive Officer (CEO) Philips (Group) Netherlands
van Husen, Georg (Boehringer Ingelheim 201804 SVP Therapeutic Area CardioMetabolism) President/Director/Head Business Group/Unit/Division Boehringer Ingelheim (Group) Germany
van Koppen, Chris J. (ElexoPharm 201201– Head of Research before Merck Sharp & Dohme NL) Chief Scientific Officer (CSO) / Chief Development Officer (CDO) ElexoPharm GmbH Germany
van Lent, Horst-Dieter (Omnibal 200906 Head Purchasing) Business Manager Omnilab (DE) (Group) Germany
Van Min, Max (Cergentis 202004 Founding Director) Managing Director Cergentis B.V. Netherlands
Van Naarden, Jacob (Loxo Oncology 201711 CBO) Chief Business Officer (CBO) Eli Lilly (Group) United States (USA)
van Pelt, Eva (Eppendorf 201912– Co-CEO joined 201710 before Leica Microsystems + Hitachi + Siemens) Chief Executive Officer (CEO) Eppendorf (Group) Germany
Van Rie, Jeroen (Bayer 201706 Crop Efficiency Trait Research expert) n. a. Bayer (Group) Germany
van Tilburg, Maurice (Euronext 201511 CEO of Euronext Amsterdam) Chief Executive Officer (CEO) Euronext (Group) Netherlands
van Tulder, Arnoud (Cryo-Save 201105 CEO) Chief Executive Officer (CEO) Esperite (Group) Netherlands
van Tunen, Arjen (Keygene 200601 CEO) Chief Executive Officer (CEO) KeyGene N.V. Netherlands
van Wieringen, Bas (PeelPioneeres 202010) n. a. PeelPioneers B.V. Netherlands
van Winsen, Joris (Labfolder 2015– Managing Director CFO) Managing Director Labforward (Group) Germany
van Zyl, Charl (UCB 202101 EVP Head Neurology Solutions + Intl Markets formerly Jado Technologies + Novartis + Lilly) Chief Executive Officer (CEO) Jado Technologies GmbH Germany
Vandenhirtz, Dirk (LemnaTec 201104 Managing Director) Managing Director Nynomic (Group) Germany
Vanderhaegen, Frederic (Tecan 201202 Head Life Sciences Business) President/Director/Head Business Group/Unit/Division Tecan (Group) Switzerland
Vangeel, Frankie (VWR 201602 Managing Director at VWR International GmbH) Managing Director Avantor (Group) Germany
Vanhoyland, Geert (Bruker 201606 Global Product Manager Materials Research at Bruker AXS) Product Manager (personnel) Bruker (Group) Germany
Vann, Christopher (Autolus 201707– COO before Roche) Chief Operating Officer (COO) Autolus Therapeutics plc (Nasdaq: AUTL) United Kingdom (GB)
VanOort, Douglas (NeoGenomics 201703 CEO) n. a. NeoGenomics Inc. (Nasdaq: NEO) United States (USA)
Varma, Suneet (Pfizer 201712 Global President of Pfizer APAC, Greater China + Global Brands) President/Director/Head Business Group/Unit/Division Pfizer (Group) United States (USA)
Varney, Michael D. (Roche 201501–202007 promoted Head of gRED before Genentech RETIRED 7/20) President/Director/Head Business Group/Unit/Division Roche (Group) United States (USA)
Vasella, Daniel (Novartis CEO 199612–201001 after 1/10 continues as Chairman) Board member, non-executive Numab (Group) Switzerland
Vater, Wulf (Bayer 199710) n. a. Bayer (Group) Germany
Vaussy, Hugues (Eurofins 201707 Finance Director) Chief Financial Officer (CFO) Eurofins (Group) Luxembourg
Vazirani, Suresh (Erba Diagnostics Mannheim 201509 Managing Director) Managing Director Erba Diagnostics Mannheim (Group) Germany
Végh, Mátyás (Creoptix 201210–201912 Managing Partner before Genetics Company LEFT 1/20) Managing Partner Creoptix AG Switzerland
Veidman, Avi (Nucleai 202007 CEO + Co-Founder) Chief Executive Officer (CEO) Nucleai (IL)
Veinbergs, Isaac (Libra Therapeutics 202009– CEO) Chief Executive Officer (CEO) Libra Therapeutics Inc. United States (USA)
Veitch, David (Basilea 201804– CEO before CCO since 201408 before Savient + BMS) Chief Executive Officer (CEO) Basilea (Group) Switzerland
Veitschegger, Andrea (ÖGMBT 201105 Managing Director) Managing Director Österreichische Gesellschaft für Molekulare Biowissenschaften und Biotechnologie (ÖGMBT) Austria
Velasco, Martin (AC Immune 201401 Board Chairman) Board member, non-executive AC Immune S.A. (Nasdaq: ACIU) Switzerland
Velden, Torsten (Bayer 201208 Bayer CropScience Country Head for Vietnam) Regional manager Bayer (Group) Germany
Veldman, Robert (Bipharma 201204 CEO) Chief Executive Officer (CEO) Bipharma B.V. Netherlands
Velling, Johannes (Germany (govt) 201502 Head Division KfW, Seed + Start-up Financing) Administrative Officer (personnel) Germany (govt) Germany
Velten, Jürgen n. a. Baden-Württemberg (govt region) Germany
Venter, J. Craig n. a. VENTER Group [Craig Venter / Claire Fraser] (Group) United States (USA)
Ventur, Yvonne (Orexo 201207 Kibion Country Manager Germany) Regional manager Mayoly Spindler (Group) Germany
Venturi, Miro (Roche 201101 Senior Biomarker + Experimental Medicine Leader) Research & Development Manager Roche (Group) Switzerland
Veraitch, Farlan (Ori Biotech 202005 CSO + Co-Founder) Chief Scientific Officer (CSO) / Chief Development Officer (CDO)
Verbraeken, Paul (Evolva 201105 Investor Relations Manager) Public Relations Manager / Investor Relations Manager Evolva (Group) Switzerland
Verghese, Jacob (Trophic Communications 201811) Public Relations Manager / Investor Relations Manager Trophic Communications GmbH Germany
Verhaeghe, Peter (Benaruca 200910) Investment Manager Benaruca (LU) (family offfice of Rudi Pauwels) Luxembourg
Verhaert, Raymond (ProteoNic 201105 CSO) Chief Scientific Officer (CSO) / Chief Development Officer (CDO) ProteoNic Biotechnology B.V. Netherlands
Verhey, Janko F. (MVIP ImagingProducts 200912 Managing Director + Co-Founder) Managing Director MVIP (Group) Germany
Verhey, Martina (MVIP ImagingProducts 200912 Managing Director + Co-Founder) Managing Director MVIP (Group) Germany
Verheyen, Frank (Techniker Krankenkasse 200901– Director of WINEG) President/Director/Head Business Group/Unit/Division Techniker Krankenkasse (Group) Germany
Verhoef, Clarence (Varex Imaging 201701– CFO) Chief Financial Officer (CFO) Varex Imaging (Group) United States (USA)
Verjee, Rehan (Merck (DE) 201809–202102 President EMD Serono before EVP Chief Marketing + Strategy Officer LEFT 2/21) President/Director/Head Business Group/Unit/Division Merck (DE) (Group) United States (USA)
Verkamman, Annemiek (HollandBIO 201912 Managing Director) Managing Director HollandBIO Netherlands
Verland, Sten (Sunstone Capital 200705– Partner Life Science Ventures) Partner (venture partner) Sunstone Life Science (Group) Denmark
Vermeylen, Krisja (Novo Group 201704 SPV Corp People + Organisation joined before 1997 before Pharmacia) President/Director/Head Business Group/Unit/Division Novo Group (Group) Denmark
Veromaa, Timo (BioTie 1998– VP RnD promoted CEO 5/05 before Schering Oy before Collagen Corp) Chief Executive Officer (CEO) Acorda Therapeutics (Group) Finland
Verrelst, Herman (Biocartis 201709– CEO before Agilent + Cartagenia + Medicim + Data4s) Chief Executive Officer (CEO) Biocartis (Group) Belgium
Vertes, Akos (George Washington Univ 2000– Prof before Associate Prof since 1991) Professor George Washington University United States (USA)
Ververken, Cedric (Confo Therapeutics 201610– CEO before Ablynx) Chief Executive Officer (CEO) Confo Therapeutics N.V. Belgium
Verwiel, Frank (ObsEva 2016– Board Director before CEO of Aptalis Pharma) n. a. ObsEva (Group) Switzerland
Verzetnitsch, Ulrike (Apceth 201612 CTO at Apceth Biopharma GmbH) Chief Technology/Technical Officer (CTO) Showa Denko (SDK) (Group) Germany
Vessey, Rupert (Celgene 201701 EVP + President RnD before Merck & Co 200906 VP Merck Research Laboratories) President/Director/Head Business Group/Unit/Division Bristol-Myers Squibb (BMS) (Group) United States (USA)
Vetter, Dirk (Perora GmbH 201306– Managing Director + Co-founder) Managing Director Perora GmbH Germany
Vetter, Udo J. (UV-Cap 201702 Founder + Managing Director) Managing Director
Veugelers, Mark (VIB 201408 Tech Watch team) IP Manager VIB (Flanders Interuniversity Institute for Biotechnology / Vlaams Instituut voor Biotechnologie) Belgium
Vianna, Eduardo (NovaGo Therapeutics 202009– Chief Development Officer before CEO) Chief Scientific Officer (CSO) / Chief Development Officer (CDO) NovaGo Therapeutics AG Switzerland
Vicari, Alain (Calypso Biotech 201703 CEO) Chief Executive Officer (CEO) Calypso Biotech (Group) Switzerland
Viehbacher, Christopher A. (Chris) (Bertarelli Group 201510 Managin Partner Gurnet Point Capital before Sanofi + GSK) Managing Partner BERTARELLI Group (family of Ernesto Bertarelli) United Kingdom (GB)
Vielsack, Claus (Stratec 201402– Executive Management Board Member for Product Development joined 1998) Board member, executive Stratec (Group) Germany
Viëtor, Henk (Oncodrone 201508 CEO before Skyline Diagnostics CEO) Chief Executive Officer (CEO) SkylineDx B.V. Netherlands
Vigneault, Francois (AbVitro 201410 CSO + Co-founder) Chief Scientific Officer (CSO) / Chief Development Officer (CDO) Bristol-Myers Squibb (BMS) (Group) United States (USA)
Vignon, Guillaume (BeiGene 201810 SVP Business Development at BeiGene Switzerland GmbH) Business Development Manager / Strategy Manager BeiGene (Group) Switzerland
Vile, Hollie (Optimum Strategic Communicatons 201710 before Hume Brophy + M:Communications) Public Relations Manager / Investor Relations Manager Optimum Strategic Communications United Kingdom (GB)
Villain-Guillot, Philippe (Nosopharm 201703 President) Chief Executive Officer (CEO) Nosopharm S.A.S. France
Vink, Patrick (Forbion 202007c– Operating Partner former COO of Cubist before Mylan + Sandoz) Partner (venture partner) Forbion Capital Partners (NL) Netherlands
Virani, Shafique (Recursion 202009 Chief Corp Development Officer formerly Roche Global Head Neuroscience Partnering) Business Development Manager / Strategy Manager Recursion Pharmaceuticals Inc. United States (USA)
Virchow, Sebastian n. a. Deutsche Bank (Group) Germany
Viribay, Miguel-Antonio (Sygnis 201504– VP Sales + Marketing before Thermo Fisher + Agilent + Life Technologies) Sales Manager / Marketing Manager Expedeon (Group) Germany
Virji, Sukaina (Suki) (Consilium 201706– joins London CSC office before 16y at Scrip/Informa) Public Relations Manager / Investor Relations Manager Consilium Strategic Communications Ltd. (CSC) United Kingdom (GB)
Vita, Giuseppe (Schering) n. a. Bayer (Group) Germany
next pagenext page 1 2 3 ... 67 68 69 ... 73 74 75  next pagenext page



Advertisement

Picture Berlin Partner Hotspot for Startups 650x80px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [iito] No Content Marketing 650x80px

» top